C Diff Foundation welcomes November as Clostridium difficile Awareness Month and it is an exciting time for patients, families, clinicians, and organizations. Governors in several states honor our efforts by signing proclamations declaring November to be Clostridium difficile Awareness Month in their states.
This year, our goal is to obtain proclamations in all 50 states
(NEW PORT RICHEY, Fla.) -- NEWS: C Diff Foundation welcomes November as Clostridium difficile Awareness Month and it is an exciting time for patients, families, clinicians, and organizations. Governors in several states honor our efforts by signing proclamations declaring November to be Clostridium difficile Awareness Month in their states.
These proclamations are available to you and can be downloaded for your use from our website: https://cdifffoundation.org/make-a-difference-november/.
This year, our goal is to obtain proclamations in all 50 states. Denise Graham, Strategic Advisor of the C Diff Foundation, proudly leads the Clostridium difficile (C. diff., C. difficile) State Proclamation effort.
Join us at the upcoming 5th Annual International C.diff. Awareness Conference and Health EXPO, taking place on November 9 and 10, 2017 at the University of Nevada - Las Vegas, Thomas and Mack Center, 2nd Floor Pavilion, Las Vegas, Nevada.
Complimentary registrations are available: https://cdifffoundation.org/registration/
According to the Centers for Disease Control and Prevention (CDC), Clostridium difficile infection (C. difficile) "has become the most common microbial cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone." Statistics provided by the CDC suggest that C. difficile cause nearly 500,000 infections in patients in the U.S. annually. In one study noted by the CDC, among infected patients, nearly 29,000 died within 30 days of being diagnosed, and more than half of those deaths (15,000) were directly attributable to a C. difficile infection.
Dale Gerding, MD, FACP, FIDSA joins 25+ internationally recognized experts in health care, academic, and industry leaders to discuss the burden of Clostridium difficile infections (C.difficile, C.diff., CDI) and prevention, treatments, diagnostics, research, clinical trials, with Microbiome research, Infection Prevention, Irritable Bowel Syndrome treatments and clinical trials, Environmental Safety, Fecal Microbiota Restoration, Antibiotic Stewardship and more.
To learn more about the program and guest speakers: https://cdifffoundation.org/cdiff2017guest-speakers/
Attendee Linda Jablonski, RN, BSN said about the 2016 conference, "The information shared at the conference provided up-to-date studies and important information that help us all save lives."
Visit https://cdifffoundation.org for more information. Contact Denise Graham for registration and media inquiries email@example.com or Mobile (202)-294-6314.
About the C Diff Foundation:
The C Diff Foundation, a 501(c)(3) established 2012, comprised of 100% volunteering professionals dedicated at supporting public health through education and advocating for C. difficile infection (CDI) prevention, treatments, environmental safety, and support worldwide.
Follow C Diff Foundation on Twitter
*IMAGE for media: Send2Press.com/300dpi/17-0928s2p-cdiff-awareness-300dpi.jpg
Related link: https://cdifffoundation.org/
This version of news story was published on and is Copr. © eNewsChannels™ (eNewsChannels.com) - part of the Neotrope® News Network, USA - all rights reserved. Information is believed accurate but is not guaranteed. For questions about the above news, contact the company/org/person noted in the text and NOT this website.